Navigation Links
Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results
Date:3/15/2011

clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, bleeding and central nervous system disorders.

Forward-looking StatementsThis press release contains forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, which are subject to the "safe harbor" created by those sections. These statements include, but are not limited to, statements regarding the Company's ability to report data this quarter from both its OMS103HP Phase 3 ACL program and its Phase 2b ophthalmology trial of OMS302; and that it may have capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. Omeros' actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors described under the heading "Risk Factors" in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 15, 2011. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future.OMEROS CORPORATION(A Development Stage Company)CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except share and per share data)(unaudited)Three Months EndedTwelve Months EndedDecember 31,December 31,2010200920102009Grant revenue

$
976

$
434

$
2,105

$
,444Operating expenses:Research and development

6,947

4,638

23,465

16,929General and administrati
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
3. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
4. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
5. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
6. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
8. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
9. Daniel K. Spiegelman Elected to Board of Directors of Omeros
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... July 13, 2014 ... Tokio veranstalteten F&E-Tagung meldete ... zur Neuausrichtung seines Forschungsrahmenprogramms. Die Tagung bot ... die fortgeschrittenen klinischen Programme und die Konzernstrategie ... Tagung bestand darin, aktuelle Meldungen zu den ...
(Date:7/13/2014)... 2014  Eli Lilly and Company (NYSE: ... non-clinical study in genetically engineered mice examining combination ... antibody N3pG and beta-secretase inhibitor BACE (LY2811376). Data ... in removing clumps of amyloid-beta protein in the ... lead to Alzheimer,s disease (AD) – than use ...
(Date:7/11/2014)... 11, 2014 /PRNewswire-iReach/ -- VAPETEK™, Inc. has announced ... for use in portable vaporizers, which contains CBD, ... in cannabis, cannabidiol offers consumers a THC-free product ... other vaporizer technology. Photo - ... 483 different compounds which are currently known, two ...
Breaking Medicine Technology:Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 2Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 3Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 4New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2
... strategic transaction processSAN DIEGO, May 7 ADVENTRX ... today announced results from its bioequivalence study of ... have comparable overall safety as Taxotere(R), the reference ... severe toxicities. However, pharmacokinetic equivalence, the primary ...
... is to Enhance Patient Safety and Reduce Health Care ... will join in a pilot program, contributing data on ... the data collected, it will be possible to identify ... patient safety while reducing overall costs to the health ...
Cached Medicine Technology:ADVENTRX Announces Results From ANX-514 Bioequivalence Study 2ADVENTRX Announces Results From ANX-514 Bioequivalence Study 3ADVENTRX Announces Results From ANX-514 Bioequivalence Study 4ADVENTRX Announces Results From ANX-514 Bioequivalence Study 5National Hemovigilance Pilot Program Launches to Track Adverse Events Associated with Blood Transfusion 2National Hemovigilance Pilot Program Launches to Track Adverse Events Associated with Blood Transfusion 3
(Date:7/14/2014)... (PRWEB) July 14, 2014 Doctor Mike ... the launch of their new company website. The Inception ... free information on chiropractic marketing. It's also a place ... Inception has to offer. , When contacted at his ... newest version of our main website. Our site is ...
(Date:7/14/2014)... IL (PRWEB) July 14, 2014 ... marketing company for mental health professionals, announced today ... Association of North Carolina (LPCANC). This new ... online marketing solutions to LPCANC members, adding exclusive ... 7 years, we have been dedicated to providing ...
(Date:7/14/2014)... New York, NY (PRWEB) July 14, 2014 ... compatibility app on iTunes, called Love Digits. The App ... singles and couples alike to quantify their compatibility using ... times, and places, two people can instantaneously test their ... and Chinese astrology measures. , The app’s five-star rating ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 EnergyFirst, ... and powder company Permalean for its great ... , Permalean, which markets its products as Jim’s ... now a part of EnergyFirst’s lineup of nutritional ... EnergyFirst over the coming year. , Founded in 1999, ...
(Date:7/14/2014)... Texas (PRWEB) July 14, 2014 ... forefront in complete spine care—from diagnosis to treatment and ... locations are either certified in or training for certification ... Theresa Adame, have recently completed the extensive program. , ... utilizing The McKenzie Method results in better outcomes for ...
Breaking Medicine News(10 mins):Health News:Doctor Mike Hamilton From Inception Chiropractic Websites Announces the Launch of Their New Website 2Health News:TherapySites Partners With the Licensed Professional Counselors Association of North Carolina to Make Online Marketing Available to All Therapists 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 3Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 2Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 3Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 2Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 3
... 11 (HealthDay News) -- Parkinson,s disease patients who receive care ... break a hip or need nursing-home placement than those treated ... American researchers looked at the medical records of all ... Between that time and 2005, 68 percent of the patients ...
... drugs as a first-line treatment for people with tuberculosis (TB) ... not been well understood. Now, researchers have discovered a key ... TB therapy. The finding potentially paves the way for the ... an infected individual even more rapidly. The study was supported ...
... THURSDAY, Aug. 11 (HealthDay News) -- What do a ... A lot more than you might expect, new research ... aquatic reptile with its embryo offers the first evidence ... that they may have had a social structure similar ...
... August 11, 2011) According to a study ... the American Society of Hematology (ASH), researchers have ... that releases stem cells from the bone marrow into the ... risk for later development of abnormalities involving loss or gains ...
... , THURSDAY, Aug. 11 (HealthDay News) -- American women ... those born in 1910 or 1960, according to researchers who analyzed ... 1935 had an average of three children per woman, compared with ... for those born in 1960, their study found. Of the ...
... 11 (HealthDay News) -- Like humans, chimpanzees are born ... to track the development of three chimpanzees, brains from ... areas of the brain that play an important role ... and creativity are immature in both chimps and humans, ...
Cached Medicine News:Health News:Parkinson's Patients May Fare Better in Neurologist's Care 2Health News:Prehistoric Water Reptile's Social Life Similar to Dolphins: Study 2Health News:Stem cell mobilization therapy found to be safe for bone marrow donors 2Health News:Stem cell mobilization therapy found to be safe for bone marrow donors 3Health News:Women Born After Great Depression Had More Children, Study Finds 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: